Cargando…
Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck
Autores principales: | Leus, A.J.G., Horváth, B., Terra, J.B., Diercks, G.F.H., Plaat, B.E.C., Oosting, S.F., Rácz, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298061/ https://www.ncbi.nlm.nih.gov/pubmed/34597438 http://dx.doi.org/10.1111/bjd.20774 |
Ejemplares similares
-
Treatment of keratinocyte carcinoma in elderly patients – a review of the current literature
por: Leus, A.J.G., et al.
Publicado: (2020) -
Age-related Differences in Tumour Characteristics and Prognostic Factors for Disease Progression in Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: LEUS, Alet J. G., et al.
Publicado: (2022) -
The Effect of Tumor Characteristics and Location on the Extent of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinoma
por: van Leer, Bram, et al.
Publicado: (2022) -
The criteria of eligibility to the extracorporeal treatment
por: Zangrillo, A
Publicado: (2012) -
IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients
por: Lamberts, A., et al.
Publicado: (2020)